Dr. Amiel Dror
Otolaryngologist. Noise-induced hearing loss, drug-induced hearing loss, vestibulopathy, Benign Paroxysmal Positional Vertigo (BPPV)
CV
Dr. Amiel Dror received his M.D. and Ph.D. degrees from the Faculty of Medicine, Tel Aviv University, under the mentorship of Prof. Karen B. Avraham. His Ph.D. focused on the mechanisms that underlie deafness as a result of SLC26A4 mutations. Human mutations in SLC26A4 lead to a non-syndromic (DFNB4) and syndromic form of deafness with enlargement of the thyroid gland (Pendred syndrome).
Today he leads a highly collaborative research laboratory affiliated with the Azrieli Faculty of Medicine, Bar-Ilan University, and is an otolaryngologist at the Galilee Medical Center in Israel.
Research in Dr. Dror's laboratory focuses on developing ways to treat and prevent hearing impairment and balance disorders that appear due to environmental damage that impairs the function of the ear. In particular, the laboratory explores the conditions under which hearing impairment following exposure to noise or an ototoxic drug is treatable and reversible. The research is motivated by therapeutic challenges and, ultimately, discoveries from the laboratory will be accessible to those suffering from hearing loss. Clinical familiarity with daily difficulties encountered by patients with hearing impairments led Dror's laboratory to promote digital accessibility for hard-of-hearing populations around the world.
Dr. Dror is participating in multiple Israeli and international studies, mentoring student and medical doctors in their research, and is currently a member of the Research Square editorial board, a preprint platform that partners with Springer Nature and Cambridge University Press. Dr. Dror is an elected member of the Israel Young Academy, and is an active member of the Israel Society for Auditory Research.
Research
Molecular basis of hearing and vestibular dysfunction
Publications
Selected publications below.
For full list, go here.
Dror AA, Kassis Karayanni N, Adi O, Daoud A, Eisenbach N, Mizrachi M, Doaa R, Francis S, Layous E, Evgeni Gutkovich Y, Taiber S, Chordekar S, Srouji S, Goldstein S, Ziv Y, Ronen O, Gruber M, Avraham KB, Sela E. Auditory Performance in Recovered SARS-COV-2 Patients. Otol Neurotol. 2021; 1;42(5).
Orvis J, Gottfried B, Kancherla J, Adkins RS, Song Y, Dror AA, Olley D, Rose K, Chrysostomou E, Kelly MC, Milon B, Matern MS, Azaiez H, Herb B, Colantuoni C, Carter RL, Ament SA, Kelley MW, White O, Bravo HC, Mahurkar A, Hertzano R. gEAR: Gene Expression Analysis Resource portal for community-driven, multi-omic data exploration. Nat Methods. 2021; 18(8):843-844
Dror AA, Morozov NG, Layous E, Mizrachi M, Daoud A, Eisenbach N, Rayan D, Kaykov E, Marei H, Barhum M, Srouji S, Avraham KB, Sela E. United by Hope, Divided by Access: Country Mapping of COVID-19 Information Accessibility and Its Consequences on Pandemic Eradication. Frontiers in Medicine. 2021; 27;7:618337.
Dror AA, Taiber S, Sela E, Handzel O, Avraham KB. A mouse model for benign paroxysmal positional vertigo with genetic predisposition for displaced otoconia. Genes, Brain and Behavior. 2020; e12635.
Last Updated Date : 24/10/2023
